AL
ACIU icon

AJO LP’s AC Immune ACIU Stock Holding History

AJO LP’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-53,670
Closed -$370K – 672
2020
Q1 		$370K Buy
+53,670
New +$420K ﹤0.01% 518

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AJO LP's ACIU Position: Q2 2020 in Review

AJO LP sold out of AC Immune (ACIU) in Q2 2020, closing a stake of 53,670 shares — an estimated $370K sold.

AJO LP first reported a position in ACIU in Q1 2020 and held it in 1 quarter. The position peaked at $370K in Q1 2020. 42 funds tracked by Wall St. Rank hold ACIU as of Q2 2020.

  • AJO LP reported no remaining AC Immune position as of Q2 2020 after selling out during the quarter.
  • AJO LP sold 53,670 AC Immune shares in Q2 2020, an estimated $370K.
  • AJO LP first reported a position in AC Immune in Q1 2020 and held it in 1 quarter.
  • AJO LP's AC Immune position peaked at $370K in Q1 2020.
  • 42 funds tracked by Wall St. Rank held AC Immune as of Q2 2020.

Based on AJO LP's 13F filing for Q2 2020, filed 12 Aug 2020.